Acne from the point of view of dermatologists and cosmetologists

Cover Page


Cite item

Full Text

Abstract

Goal. To compare approaches taken by dermatologists and cosmetologists to management of patients suffering from acne taking into consideration the clinical picture of the disease and patient’s age and sex, and to assess the efficacy and safety of an external therapy with azelaic acid in acne patients. Materials and methods. A study conducted by the MIR-O-MED Clinic involved 300 patients aged 14-48 with different forms of acne of different severity. To analyze particular features of the clinical picture of acne as well as age and sex differences in acne patients consulting dermatologists and cosmetologists, researchers collected statistics on the basis of primary medical documents, and then grouped the data by principal and additional indices. Both dermatologists and cosmetologists recommended azelaic acid in the form of a monotherapy and in a combination with cosmetic products as first-line treatment of primary acne patients. The efficacy and safety of an external therapy of acne patients with azelaic acid was assessed. Results. Clinical recovery and considerable clinical improvement was achieved in 94% of the patients who received an external therapy with azelaic acid. Conclusion. A lack of contradictions in coordinated measures taken by cosmetologists and dermatologists predetermines the correct order and combination of basic treatment measures involving tolerable and timely cosmetic correction, which is a prerequisite for solving the acne problem. Azelaic acid used by these categories of physicians for treatment of acne patients substantially improves the quality and efficacy of therapeutic measures.

About the authors

O. A. Katkhanova

Kuban State Medical University

Author for correspondence.
Email: okathanova@mail.ru
Russian Federation

M. A. Katkhanov

OOO "MIR-O-MED"

Email: noemail@neicon.ru
Russian Federation

References

  1. Nast A., Dreno B., Betolli V. et al. European evidence-based S3 guidelines for the treatment of acne J Eur Acad Dermatol Venereol 2012; 26 (Suppl.): 1-29.
  2. Potekaev N.N., Goriachkina M.V. Certain aspects of diagnostics and treatment of refractory acne in the women. Сііп Dermatol and Venerol 2012; 1: 72-78. [Потекаев Н.Н., Горячкина М.В. Некоторые аспекты диагностики и лечения рефрактерных акне у женщин. Клин дерматол и венерол 2012; 1: 72-77.]
  3. Volkova Ye.N., Grigoriyeva A.A., Yelistratova I.V. Pathogenic therapy of acne patients Vestn Dermatol i Venerol 2012; 6: 82-89. [Волкова Е.Н., Григорьева А.А., Елистратова И.В. Патогенетическая терапия больных акне. Вест дерматол и венерол 2012; 6: 82-89.]
  4. Dreno B., Layton A., Zouboulis C.C. et al. Adult female acne: a new paradigm J Eur Acad Dermatol Venereol 2013; 27: 1063-1070.
  5. Choi C., Lee D., Kim H. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25: 454-461.
  6. Yutskovskaya Ya.A., Taran M.G., Dvoryaninova I.E. Printsipy naruzhnogo lecheniya akne v sochetanii s apparatnymi metodami vozdeystviya. Eksper i klin dermatokosmetol 2012; 3: 20-23. [Юцковская Я.А., Таран М.Г., Дворянинова И.Е. Принципы наружного лечения акне в сочетании с аппаратными методами воздействия. Экспер и клин дерматокосметол 2012; 3: 20-23.]
  7. Saybel' A.V. Skinoren i pilingi v lechenii akne Kosmetic International 2012; 2: 34-36. [Сайбель А.В. Скинорен и пилинги в лечении акне Kosmetic International 2012; 2: 34-36.]
  8. Butov Yu.S., Akhtyamov S.N., Demina O.M. i soavt. Fotodinamicheskaya terapiya ugrevoy bolezni. Rus J Skin and Sex Transmit Diseases 2007; 3: 64-67. [Бутов Ю.С., Ахтямов С.Н., Демина О.М. и соавт. Фотодинамическая терапия угревой болезни. Рос журн кож и вен бол 2007; 3: 64-67.]
  9. Zouboulis C.C., Eady A., Philpott M. et al. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152.
  10. Lipova E.V., Shkoda S.A., Glazko I.I. i soavt. Innovatsionnye tekhnologii v naruzhnoy terapii akne. Modern Probl Dermatovenerol, Immunol and Medi Cosmetol 2011; 2: 54-60. [Липова Е.В., Шкода С.А., Глазко И.И. и соавт. Инновационные технологии в наружной терапии акне. Соврем пробл дерматовенерол, иммунол и врач косметол 2011; 2: 54-60.]
  11. Holland D.B., Jeremy A.H. The role of inflammation in the pathogenesis of acne and acne scarring. Semin Cutan Med Surg 2005; 24: 79-83.
  12. Fritsch M., Orfanos C.E., Zouboulis C.C. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol 2001; 116:793-800.
  13. Dukhanin A.S. The current criteria for rational pharmacotherapy of acne in women. The viewpoint of a clinical pharmacologist. Clin Dermatol and Venerol 2012; 2: 108-117. [Духанин A.C. Современные критерии рациональной фармакотерапии акне у женщин. Взгляд клинического фармаколога. Клин дерматол и венерол 2012; 2: 108-117.]
  14. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol 2008; 7: 13-16.
  15. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000; 43: S47-50.
  16. Gollnick H.P., Graupe K., Zaumseil R.P. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two doubleblind clinical comparative studies. J Dtsch Dermatol Ges 2004; 2: 841-847.
  17. Tlish M.M., Katkhanova O.A., Kuznetsova T.G., Naatyzh Zh.Yu. Innovations in the external therapy of acne. Vestn Dermatol i Venerol 2013; 2: 79-83. [Тлиш М.М., Катханова О.А., Кузнецова Т.Г., Наатыж Ж.Ю. Инновации наружной терапии акне. Вестн дерматол и венерол 2013; 2: 79-83.]

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Katkhanova O.A., Katkhanov M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies